Baker McKenzie represented H.Lundbeck A/S (Lundbeck) in the transaction, Cooley represented Longboard Pharmaceuticals and Wilson Sonsini Goodrich & Rosati represented Evercore, Longboard’s financial advisor. H. Lundbeck...
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
TransMedics Group’s Acquisition of Organ Support and Heart Preservation Transport System Assets from Bridge to Life
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
Turnstone Biologics Corp.’s $80 Million Initial Public Offering
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
ThoughtSpot’s $200 Million Acquisition of Mode Analytics
Cooley advises ThoughtSpot on the deal. ThoughtSpot announced it has signed a definitive agreement to acquire Mode Analytics in a cash and equity deal valued at $200...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Amgen’s Acquisition of Horizon Therapeutics
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
AstraZeneca’s Acquisition of Neogene Therapeutics
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
Bristol Myers Squibb’s $4.1 Billion Acquisition of Turning Point Therapeutics
Cooley advised Turning Point Therapeutics, while Kirkland & Ellis advised Bristol Myers Squibb on the deal. Bristol Myers Squibb (NYSE:BMY), a global biopharmaceutical company, announced its...
Grindr’s Merger with Tiga Acquisition Corp.
Cooley advised Grindr on the deal while Milbank LLP represented Tiga Acquisition Corp. Grindr, the #1 social network for the LGBTQ+ community, announced its definitive agreement to...
Great Hill Partners’ Investment in Prodege
Cooley LLP advised Prodege on the deal. Prodege, a cutting-edge marketing and consumer insights platform, announced its definitive agreement to secure a major investment from private equity...
Alvotech’s Merger with Oaktree Acquisition Corp. II
Cooley and Arendt advised Alvotech Holdings, while Kirkland & Ellis, working alongside Walkers and King & Spalding and Elvinger Hoss Prussen, advised Oaktree Acquisition Corp. II...